The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Liposomal irinotecan (Brand name: Onivyde)
- Manufactured by
Merrimack Pharmaceuticals, Inc.
FDA-approved indication: For use in combination with 5-fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas that has progressed following gemcitabine-based therapy.
National Library of Medicine Drug Information PortalMedline Plus Health Information